[1]Varlet,Didier;Fourmaintraux,Eric;Depreux,Patrick;Lesieur,Daniel[Heterocycles,2000,vol.53,#4,p.797-804]
[2]CurrentPatentAssignee:PFIZERINC-US2748129,1954,A
[3]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2007/117796,2007,A1Locationinpatent:Page/Pagecolumn14
[4]Locationinpatent:schemeortableJin,Hongxia;Randazzo,James;Zhang,Peng;Kador,PeterF.[JournalofMedicinalChemistry,2010,vol.53,#3,p.1117-1127]
[1]Wollweber;Horstmann;Stoepel;Garthoff;Puls;Krause;Thomas[Arzneimittel-Forschung/DrugResearch,1981,vol.31,#2,p.279-288]
[1]Nagarajan,K.;Arya,V.P.;George,T.;Bhat,G.A.;Kulkarni,Y.S.;etal.[IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,1982,vol.21,#10,p.949-952]
[1]Varlet,Didier;Fourmaintraux,Eric;Depreux,Patrick;Lesieur,Daniel[Heterocycles,2000,vol.53,#4,p.797-804]
[1]Varlet,Didier;Fourmaintraux,Eric;Depreux,Patrick;Lesieur,Daniel[Heterocycles,2000,vol.53,#4,p.797-804]
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101